Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.
作者信息
Braitsch Krischan, Schmalbrock Laura K, Jung Paul, Bumeder Irmgard, Kiewe Philipp, Hecker Judith S, Verbeek Mareike, Westermann Jörg, Bullinger Lars, Keller Ulrich, Bassermann Florian, Krönke Jan, Götze Katharina S, Rieger Kathrin
机构信息
Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.
Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
出版信息
Hemasphere. 2022 Aug 9;6(9):e759. doi: 10.1097/HS9.0000000000000759. eCollection 2022 Sep.
Abstract
摘要
Zotero 插件